Skip to main content

Advertisement

SpringerLink
Log in

Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma

  • Original paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most frequently diagnosed malignant tumors in North China. We have identified that Wnt2/β-catenin pathway is activated in ESCC cells and sodium nitroprusside (SNP) and siRNA against β-catenin not only inhibit the expressions of β-catenin and its major downstream effectors including c-myc and cyclin D1 but induce cell cycle arrest and apoptosis. The purpose of the present study was to analyze the relationship between pathological parameters including invasion depth and lymph node metastasis and the expressions of β-catenin, c-myc, and cyclin D1 in order to evaluate their values of prognosis in patients with ESCC. The expressions of β-catenin, c-myc, and cyclin D1 were detected immunohistochemically in the resected cancer tissues from 40 patients with ESCC. The β-catenin expression was reduced in 22 (55.0%) patients, which was closely correlated with invasion depth (P = 0.023) and lymph node metastasis (P = 0.003). There was the positive c-myc expression in 21 (52.5%), which was significantly correlated with invasion depth (P = 0.009) and lymph node metastasis (P = 0.001). Furthermore, the results of survival rates analyzed by Kaplan–Meier curve revealed that patients with the reduced expression of β-catenin had a poorer prognosis than those with the preserved expression (P = 0.031), and patients with the positive expression of c-myc also had a significantly poorer prognosis than those with the negative expression (P = 0.008). These findings demonstrate that β-catenin pathway plays a crucial role in the progression of ESCC, suggesting that both β-catenin and c-myc may be used as markers for predicting the prognosis of patients with ESCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29.

    Article  PubMed  CAS  Google Scholar 

  2. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer. 1996;69:225–35.

    Article  PubMed  CAS  Google Scholar 

  3. Conacci-Sorrell M, Zhurinsky J, Ben-Ze’ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest. 2002;109:987–91.

    PubMed  CAS  Google Scholar 

  4. Day TF, Yang Y. Wnt and Hedgehog signaling pathways in bone development. J Bone Joint Surg. 2008;90:19–24.

    Article  PubMed  Google Scholar 

  5. Muzio L. A possible role for the Wnt-1 pathway in oral carcinogenesis. Crit Rev Oral Biol Med. 2001;12:152–65.

    Article  PubMed  Google Scholar 

  6. Holcombe RF, Marsh JL, Waterman ML, et al. Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol. 2002;55:220–6.

    Article  PubMed  CAS  Google Scholar 

  7. Lustig B, Behrens J. The Wnt signaling pathway and its roles in tumor development. J Cancer Res Clin Oncol. 2003;129:199–221.

    PubMed  CAS  Google Scholar 

  8. Krieghoff E, Behrens J, Mayr B. Nucleo-cytoplasmic distribution of β-catenin is regulated by retention. J Cell Sci. 2006;119:1453–63.

    Article  PubMed  CAS  Google Scholar 

  9. Willert K, Jones KA. Wnt signaling: is the party in the nucleus? Genes Dev. 2006;20:1394–404.

    Article  PubMed  CAS  Google Scholar 

  10. Barbara G, De Giorgio R, Stanghellini V, et al. Neutral endopeptidase (EC 3.4.24.11) downregulates the onset of intestinal inflammation in the nematode infected mouse. Gut. 2003;52:1457–64.

    Article  PubMed  CAS  Google Scholar 

  11. Poston RS Jr, Billingham ME, et al. Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease. Ann Thorac Surg. 1997;64:1004–12.

    Article  PubMed  Google Scholar 

  12. Hou G, Xue L, Lu Z, et al. An activated mTOR/p70S6 K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Cancer Lett. 2007;253:236–48.

    Article  PubMed  CAS  Google Scholar 

  13. Kase S, Sugio K, Yamazaki K, et al. Expression of E-cadherin and β-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res. 2000;6:4789–96.

    PubMed  CAS  Google Scholar 

  14. Tang S, Chang W, Su Y, et al. Myc pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. Cancer Lett. 2009;273:35–43.

    Article  PubMed  CAS  Google Scholar 

  15. Bani-Hani K, Martin IG, Hardie LJ, et al. Prospective study of cyclin D1 overexpression in Barrett’s esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst. 2000;92:1316–21.

    Article  PubMed  CAS  Google Scholar 

  16. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–52.

    Article  PubMed  CAS  Google Scholar 

  17. Tachibana M, Kinugasa S, Yoshimura H, et al. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg. 2005;189:98–109.

    Article  PubMed  Google Scholar 

  18. Conroy T, Etienne PL, Adenis A, et al. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the esophagus: response, toxicity, quality of life and survival. Ann Oncol. 2002;13:721–9.

    Article  PubMed  CAS  Google Scholar 

  19. Nair KS, Naidoo R, Chetty R. Expression of cell adhesion molecules in esophageal carcinoma and its prognostic value. J Clin Pathol. 2005;58:343–51.

    Article  PubMed  CAS  Google Scholar 

  20. Deng YZ, Chen PP, Wang Y, et al. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through β-catenin-T-cell factor/lef signaling. J Biol Chem. 2007;282:36571–81.

    Article  PubMed  CAS  Google Scholar 

  21. Hsu P, Li A, Wang Y, et al. Reduced membranous β-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus. J Thorac Cardiovasc Surg. 2008;135:1029–35.

    Article  PubMed  Google Scholar 

  22. Retera JM, Leers MP, Sulzer MA, et al. The expression of β-catenin in non-small-cell lung cancer: a clinicopathological study. J Clin Pathol. 1998;51:891–4.

    Article  PubMed  CAS  Google Scholar 

  23. Dvory-Sobol H, Sagiv E, Kazanov D, et al. Targeting the active ß-catenin pathway to treat cancer cells. Mol Cancer Ther. 2006;5:2861–71.

    Article  PubMed  CAS  Google Scholar 

  24. Calvo R, Drabkin HA. Embryonic genes in cancer. Ann Oncol. 2000;11:207–18.

    Article  PubMed  Google Scholar 

  25. Uraguchi M, Morikawa M, Shirakawa M, et al. Activation of Wnt family expression and signaling in squamous cell carcinomas of the oral cavity. J Dent Res. 2004;83:327–32.

    Article  PubMed  CAS  Google Scholar 

  26. Nakopoulou L, Mylona E, Papadaki I, et al. Study of phospho-β-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome. Mod Pathol. 2006;19:556–63.

    Article  PubMed  CAS  Google Scholar 

  27. Veeramachaneni NK, Kubokura H, Lin L, et al. Down-regulation of β-catenin inhibits the growth of esophageal carcinoma cells. J Thorac Cardiovasc Surg. 2004;127:92–8.

    Article  PubMed  CAS  Google Scholar 

  28. You Z, Saims D, Chen S, et al. Wnt signaling promotes oncogenic transformation by inhibiting c-myc–induced apoptosis. J Cell Biol. 2002;157:429–40.

    Article  PubMed  CAS  Google Scholar 

  29. Cowling VH, D’Cruz CM, Chodosh LA, et al. c-myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1. Mol Cell Biol. 2007;27:5135–46.

    Article  PubMed  CAS  Google Scholar 

  30. Muncan V, Sansom OJ, Tertoolen L, et al. Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf4 target gene c-myc. Mol Cell Biol. 2006;26:8418–26.

    Article  PubMed  CAS  Google Scholar 

  31. Wolter F, Akoglu B, Clausnitzer A, et al. Down regulation of the cyclin D1/CDK4 complex occurs during resveratrol induced cell cycle arrest in colon cancer cell lines. J Nutr. 2001;131:2197–203.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Tumor Molecular Surgery, The First Affiliated Hospital, Zhengzhou University, 1 Jianshedonglu Road, Zhengzhou, Henan, 450052, China

    Wei Wang & Lexun Xue

  2. Laboratory for Cell Biology, Department of Biology, Zhengzhou University, 100 Kexue Ave, Zhengzhou, Henan, 450001, China

    Lexun Xue

  3. Department of Pathology, College of Basical Medicine, Zhengzhou University, 100 Kexue Ave, Zhengzhou, Henan, 450001, China

    Pengju Wang

  4. Department of Biology, Zhengzhou University Medical College, 40 Daxue Road, Zhengzhou, Henan, 450052, China

    Lexun Xue

Authors
  1. Wei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lexun Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pengju Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lexun Xue.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, W., Xue, L. & Wang, P. Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma. Med Oncol 28, 163–169 (2011). https://doi.org/10.1007/s12032-010-9436-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-010-9436-0

Keywords

Search

Navigation